NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NANO Nuclear Energy, Inc. (NASDAQ: NNE) between May 8, 2024 and July 18, 2024, both dates inclusive (the "Class Period"), of the important October 8, 2024 lead plaintiff deadline. SO WHAT: If you purchased NNE securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Arbor Realty Trust, Inc. (NYSE: ABR) between May 7, 2021 and July 11, 2024, both dates inclusive (the "Class Period"), of the important September 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased Arbor Realty securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem ...

Austin, Texas, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fastn, is redefining how enterprise approach software application development with its innovative composable architecture platform, announced a $2.6M Seed funding round today. The round was led by LiveOak Ventures and Antler, positioning Fastn at the forefront of enabling composable architecture, with backing from notable investors, including Netlify Co-Founder and MACH Alliance executive board member Chris Bach and Loop Co-Founder Kyle Hency. As the digital ...

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sprinklr, Inc. (NYSE: CXM) between March 29, 2023 and June 5, 2024, both dates inclusive (the "Class Period"), of the important October 15, 2024 lead plaintiff deadline. SO WHAT: If you purchased Sprinklr securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO D ...

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Starbucks Corporation (NASDAQ: SBUX) between November 2, 2023 and April 30, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 28, 2024. SO WHAT: If you purchased Starbucks securities during t ...

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vicor Corporation (NASDAQ: VICR) between April 26, 2023 and February 22, 2024, both dates inclusive (the "Class Period"), of the important September 23, 2024 lead plaintiff deadline. SO WHAT: If you purchased Vicor common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem ...

NEW YORK, Sept. 02, 2024 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., September 2, 2024. Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of CAE Inc. (NYSE: CAE) between February 11, 2022 and May 21, 2024, both dates inclusive (the "Class Period"), of the important September 16, 2024 lead plaintiff deadline. SO WHAT: If you purchased CAE stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arr ...

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of Endava plc (NYSE: DAVA) between May 23, 2023 and February 28, 2024, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 25, 2024. SO WHAT: If you purchased Endava securities during the Class P ...

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DXC Technology Company (NYSE: DXC) between May 26, 2021 and May 16, 2024, both dates inclusive (the "Class Period"), of the important October 1, 2024 lead plaintiff deadline. SO WHAT: If you purchased DXC common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT ...

文章核心观点 - 公司Outset Medical被指在2022年8月1日至2024年8月7日期间做出了虚假或误导性陈述,未能披露以下信息[4]: 1) Tablo产品被用于连续性肾脏替代治疗,这并非美国FDA批准的适应症之一 2) 因此Outset Medical很可能需要提交额外的510(k)申请用于Tablo产品 3) 存在Outset Medical可能暂停Tablo产品销售直至FDA批准新适应症的重大风险 4) Outset Medical缺乏执行Tablo销售增长的销售团队和流程 5) 上述因素将对公司的收入增长产生不利影响 6) 因此公司关于业务、运营和前景的积极声明存在重大误导性和缺乏合理依据 根据目录分别总结 1. 文章概述 - 罗森律师事务所代表Outset Medical公司证券购买者提起集体诉讼[1][2] - 诉讼时间范围为2022年8月1日至2024年8月7日[1] - 如果您在此期间购买了Outset Medical证券,您可能有权获得赔偿[1][2] 2. 诉讼详情 - 公司涉嫌在上述期间做出虚假或误导性陈述,未能披露以下信息[4]: 1) Tablo产品被用于连续性肾脏替代治疗,这并非FDA批准的适应症 2) 公司很可能需要提交额外的510(k)申请用于Tablo产品 3) 存在公司可能暂停Tablo产品销售的重大风险 4) 公司缺乏执行Tablo销售增长的销售团队和流程 5) 上述因素将对公司的收入增长产生不利影响 6) 因此公司关于业务、运营和前景的积极声明存在重大误导性和缺乏合理依据 3. 加入诉讼 - 如果您在上述期间购买了Outset Medical证券,您可以通过以下方式加入集体诉讼[2][5]: 1) 访问https://rosenlegal.com/submit-form/?case_id=17760 2) 致电Phillip Kim律师,电话866-767-3653 3) 发送电子邮件至case@rosenlegal.com